Endurant Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-38,494
Closed -$591K 75
2020
Q2
$591K Buy
+38,494
New +$591K 0.03% 49